Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Normal breast epithelial MCF-10A cells to evaluate the safety of carbon dots
Publication

Publications

Normal breast epithelial MCF-10A cells to evaluate the safety of carbon dots

Title
Normal breast epithelial MCF-10A cells to evaluate the safety of carbon dots
Type
Article in International Scientific Journal
Year
2021
Authors
Silva, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Duarte, D
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Crista, DMA
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. View Authenticus page Without ORCID
Joaquim C G E Esteves da Silva
(Author)
FCUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Journal
Vol. 12
Pages: 245-253
Other information
Authenticus ID: P-00T-820
Abstract (EN): The human normal breast cell line MCF-10A is being widely used as a model in toxicity studies due to its structural similarity to the normal human mammary epithelium. Over the years, application of carbon dots (C-dots) in biomedicine has been increasing due to their photoluminescence properties, biocompatibility, biosafety and possible applications in bioimaging and as drug carriers. In this work we prepared three different C-dots from the same set of carbon and nitrogen precursors (citric acid and urea, respectively) via three distinct bottom-up synthetic routes and their safety was tested against the normal breast cell line MCF-10A. The characterization results demonstrated a similar size range and composition for all the C-dots. The MCF-10A cells were treated with different concentrations of C-dots for 24, 48 and 72 h to evaluate the cell viability over time. For the 24 h incubation, there were no significant decreases in the viability of the MCF-10A cells. For the 48 h treatment, there was a significant decrease in the viability of the cells treated with calcination-based C-dots, but without significant cellular viability changes for microwave and hydrothermal-based C-dots. For 72 h, cells treated with hydrothermal-based C-dots have the most promising viability profile. Also, compared with paclitaxel, these C-dots have a safety profile very close to that of an antineoplastic in non-tumor cells. Our results suggest that these new C-dots have potential as imaging candidates or biosensing tools as well as drug carriers, and further investigation in animal models is needed for future application in medicine.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 9
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Proceedings of the 3rd IPLeiria's International Health Congress Abstracts (2016)
Article in International Scientific Journal
Tomás, CC; Oliveira, E; Sousa, D; Uba Chupel, M; Furtado, G; Rocha, C; Lopes C; Ferreira, P; Alves, C; Gisin, S; Catarino, E; Carvalho, N; Coucelo, T; Bonfim, L; Silva, C; Franco, D; González, JA; Jardim, HG; Silva, R; Baixinho, CL...(mais 1673 authors)

Of the same journal

Seasoning antimalarial drugs' action: chloroquine bile salts as novel triple-stage antiplasmodial hits (2024)
Article in International Scientific Journal
Silva, AT; Oliveira, I; Duarte, D; Moita, D; Prudencio, M; Nogueira, F; Ferraz, R; Eduardo F Marques; Paula Gomes
Discovery of hybrid Glypromate conjugates with neuroprotective activity against paraquat-induced toxicity (2024)
Article in International Scientific Journal
Silva-Reis, SC; Costa, VM; da Silva, DC; David M Pereira; Correia, XC; García-Mera, X; Rodriguez Borges, JE; Sampaio-Dias, IE
Development of potent CPP6-gemcitabine conjugates against human prostate cancer cell line (PC-3) (2020)
Article in International Scientific Journal
Correia, C; Xavier, CPR; Duarte, D; Ferreira, A; Moreira, S; Helena Vasconcelos, MH; Nuno Vale
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-08 at 04:12:12 | Privacy Policy | Personal Data Protection Policy | Whistleblowing